PG
PROCTER & GAMBLE Co
$145.10
-0.98%
$346.2B
No data for this timeframe.
Vol
Market Cap$346.2B
Cap SizeMega Cap
Analyst ConsensusBuy (61%)
Inst. Holders13 funds
Inst. Value$59.5B
Inst. Activity2 buys / 0 sells
Insider Activity0B / 8S
Insider Net $-$40.9M
Reddit Sentiment33° Cool
SEC Reports4
Congressional8 trades
Exchange NYSE·Sector Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics·Inc. OH·CIK 0000080424·Prev Close $146.54
Recent Activity
Jul 27, 2026
earnings_calendar
PG Q4 2026 Earnings After Market Close — 2026-07-27
EPS est: $1.58 | Rev est: $22.2B
Jun 4, 2026
SEC
The Sixth Circuit affirmed the district court's denial of a preliminary injunction sought by Scotts Miracle-Gro against
COURT-RULING — Impact 5/10
Jun 4, 2026
Event
The Scotts Co. LLC v. The Procter & Gamble Co.
Court ruling from Court of Appeals for the Sixth Circuit. Docket: 25-3555
May 31, 2026
SEC
JP Morgan upgrades PG to Overweight — PT $165 (+15.0%)
ANALYST-UPGRADE — Impact 4/10
Apr 27, 2026
Congress
David Taylor buy
$1,001 - $15,000 — House
Apr 27, 2026
Congress
David Taylor buy
$1,001 - $15,000 — House
Apr 24, 2026
SEC
Procter & Gamble reported Q3 FY2026 results showing 3% organic sales growth and 3% core EPS growth, driven by volume and
8-K — Impact 5/10
Mar 10, 2026
Insider
ARNOLD CRAIG sold 161 shares
Director @ $0.00 ($0.00)
Price Targets
$163.77
+10.2% upside
Buy
Current $148.67
Low $145.00
Median $164.00
High $186.00
22 analysts
$145.00
$186.00
Analyst Ratings
8Strong Buy
14Buy
13Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 27, 2026 | UBS | MAINTAIN | Buy → Buy |
| Apr 27, 2026 | TD Cowen | MAINTAIN | Hold → Hold |
| Apr 27, 2026 | Wells Fargo | MAINTAIN | Overweight → Overweight |
| Apr 27, 2026 | Evercore ISI Group | MAINTAIN | In-Line → In-Line |
| Apr 17, 2026 | JP Morgan | MAINTAIN | Overweight → Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.42 | $1.37 — $1.46 | -4% YoY | 18 |
| Next Q | $1.97 | $1.93 — $2.07 | -1% YoY | 14 |
| Current FY | $6.90 | $6.83 — $7.02 | 1% YoY | 23 |
| Next FY | $7.09 | $6.96 — $7.34 | 3% YoY | 23 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $34.0B | — |
| MORGAN STANLEY | $7.0B | — |
| NORGES BANK | $4.7B | NEW |
| BANK OF AMERICA CORP | $4.1B | — |
| FMR LLC | $3.9B | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 10, 2026 | ARNOLD CRAIG | A | $0.00 |
| Mar 10, 2026 | JIMENEZ JOSEPH | A | $0.00 |
| Mar 10, 2026 | McCarthy Christine | A | $0.00 |
| Mar 10, 2026 | McEvoy Ashley | A | $0.00 |
| Mar 10, 2026 | Portman Robert | A | $0.00 |
Reddit Sentiment
33°▼
Cool
Bearish
Neutral
Bullish
Congressional Trades
5 members: 5 buys, 3 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| David Taylor | R | BUY | $1,001 - $15,000 |
| David Taylor | R | BUY | $1,001 - $15,000 |
| John Boozman | R | SELL | $1,001 - $15,000 |
13 institutional holders with $59.5B total value (414,971,929 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, NORGES. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 237,459,756 | $34.0B | 57.2% | — |
| 2 | MORGAN STANLEY | 48,823,274 | $7.0B | 11.8% | — |
| 3 | NORGES BANK | 32,550,300 | $4.7B | 7.8% | NEW |
| 4 | BANK OF AMERICA CORP /DE/ | 28,784,316 | $4.1B | 6.9% | — |
| 5 | FMR LLC | 27,332,066 | $3.9B | 6.6% | — |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 18,779,055 | $2.7B | 4.5% | NEW |
| 7 | WELLS FARGO & COMPANY/MN | 13,878,179 | $2.0B | 3.3% | — |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 2,986,061 | $427.9M | 0.7% | DOUBLED +272.3% |
| 9 | YACKTMAN ASSET MANAGEMENT LP | 1,918,353 | $274.9M | 0.5% | — |
| 10 | TWO SIGMA INVESTMENTS, LP | 1,463,914 | $209.8M | 0.4% | ADD +59.3% |
| 11 | Mawer Investment Management Ltd. | 896,693 | $128.5M | 0.2% | TRIM -45.3% |
| 12 | DODGE & COX | 90,831 | $13.0M | 0.0% | — |
| 13 | Cullen Capital Management, LLC | 9,131 | $1.3M | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 32,550,300 | — | $4.7B | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 802,150 | 2,986,061 | +272.3% | $427.9M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 892,060 | 1,421,129 | +59.3% | $218.4M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 802,150 | — | $123.3M | 2025-Q3 |
| NORGES BANK | EXIT | 32,008,815 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 32,008,815 | — | $5.1B | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 21,900 | 892,060 | +3973.3% | $142.1M | 2025-Q2 |
| Mawer Investment Management Ltd. | TRIM | 2,001,866 | 1,094,434 | -45.3% | $186.5M | 2025-Q1 |
| NORGES BANK | EXIT | 31,282,211 | 0 | -100.0% | $0.00 | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 417,093 | 0 | -100.0% | $0.00 | 2025-Q1 |
| Mawer Investment Management Ltd. | TRIM | 2,697,121 | 2,001,866 | -25.8% | $335.6M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 16,422,470 | — | $2.8B | 2024-Q3 |
12 unique insiders with 8 transactions. Net insider value: -$40.9M ($0.00 bought, $40.9M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | ARNOLD CRAIG | Director | A | 161 | $0.00 | $0.00 |
| Mar 10, 2026 | JIMENEZ JOSEPH | Director | A | 273 | $0.00 | $0.00 |
| Mar 10, 2026 | McCarthy Christine M | Director | A | 209 | $0.00 | $0.00 |
| Mar 10, 2026 | McEvoy Ashley | Director | A | 161 | $0.00 | $0.00 |
| Mar 10, 2026 | Portman Robert Jones | Director | A | 193 | $0.00 | $0.00 |
| Mar 10, 2026 | Kempczinski Christopher J | Director | A | 201 | $0.00 | $0.00 |
| Mar 10, 2026 | Portman Robert Jones | Director | A | 49 | $0.00 | $0.00 |
| Feb 27, 2026 | Francisco Ma. Fatima | CEO - Baby, Fem & Family Care | SELL | 5,249 | $165.29 | $867.6K |
| Feb 19, 2026 | Whaley Susan Street | Chief Legal Officer & Secy | SELL | 1,809 | $159.46 | $288.5K |
| Feb 17, 2026 | Whaley Susan Street | Chief Legal Officer & Secy | A | 11.485 | $0.00 | $0.00 |
| Feb 17, 2026 | Francisco Ma. Fatima | CEO - Baby, Fem & Family Care | A | 57.003 | $0.00 | $0.00 |
| Feb 13, 2026 | Aguilar Moses Victor Javier | Chf Rsch, Dev & Innov Officer | M | 15,169 | $0.00 | $0.00 |
| Feb 13, 2026 | Aguilar Moses Victor Javier | Chf Rsch, Dev & Innov Officer | SELL | 15,169 | $162.28 | $2.5M |
| Feb 13, 2026 | Aguilar Moses Victor Javier | Chf Rsch, Dev & Innov Officer | M | 15,169 | $91.07 | $1.4M |
| Feb 12, 2026 | Moeller Jon R | Exec. Chairman of the Board | SELL | 162,232 | $162.45 | $26.4M |
| Feb 12, 2026 | Moeller Jon R | Exec. Chairman of the Board | M | 162,232 | $113.23 | $18.4M |
| Feb 12, 2026 | Moeller Jon R | Exec. Chairman of the Board | M | 162,232 | $0.00 | $0.00 |
| Feb 12, 2026 | Coombe Gary A | CEO - Grooming | M | 36,093 | $0.00 | $0.00 |
| Feb 12, 2026 | Coombe Gary A | CEO - Grooming | SELL | 36,093 | $162.33 | $5.9M |
| Feb 12, 2026 | Coombe Gary A | CEO - Grooming | M | 36,093 | $78.52 | $2.8M |
| Feb 11, 2026 | Moeller Jon R | Exec. Chairman of the Board | M | 11,036 | $0.00 | $0.00 |
| Feb 11, 2026 | Moeller Jon R | Exec. Chairman of the Board | SELL | 11,036 | $160.00 | $1.8M |
| Feb 11, 2026 | Moeller Jon R | Exec. Chairman of the Board | M | 11,036 | $113.23 | $1.2M |
| Feb 11, 2026 | Purushothaman Balaji | Chief Human Resources Officer | M | 12,827 | $0.00 | $0.00 |
| Feb 11, 2026 | Purushothaman Balaji | Chief Human Resources Officer | SELL | 12,827 | $160.31 | $2.1M |
| Feb 11, 2026 | Purushothaman Balaji | Chief Human Resources Officer | M | 12,827 | $91.07 | $1.2M |
| Feb 4, 2026 | Francisco Ma. Fatima | CEO - Baby, Fem & Family Care | SELL | 8,000 | $158.00 | $1.3M |
| Nov 17, 2025 | Coombe Gary A | CEO - Grooming | A | 63.689 | $0.00 | $0.00 |
4 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 4.5/10.
BULLISH
ANALYST-UPGRADE
4/10
JP Morgan upgrades PG to Overweight — PT $165 (+15.0%)
May 31, 2026
BULLISH
COURT-RULING
5/10
The Sixth Circuit affirmed the district court's denial of a preliminary injunction sought by Scotts
Jun 4, 2026
NEUTRAL
8-K
5/10
Procter & Gamble reported Q3 FY2026 results showing 3% organic sales growth and 3% core EPS growth,
Apr 24, 2026
NEUTRAL
8-K
4/10
Procter & Gamble reported Q3 fiscal 2026 revenue of $21.2 billion (7% YoY growth, 3% organic) and di
Apr 24, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (61% buy). Based on 36 analysts: 8 strong buy, 14 buy, 13 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$163.77 mean target
+10.2% upside
Buy (2.04)
$145.00 Low
$186.00 High
| Metric | Value |
|---|---|
| Current Price | $148.67 |
| Target Low | $145.00 |
| Target Mean | $163.77 |
| Target Median | $164.00 |
| Target High | $186.00 |
| # Analysts | 22 |
| Recommendation | Buy (2.04) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.42 | $1.37 | $1.46 | -3.9% | -0.2% | 0↑ 15↓ | $21.4B | 2.6% | 18 |
| Next Q 2026-09-30 |
$1.97 | $1.93 | $2.07 | -0.8% | +0.1% | 0↑ 12↓ | $23.0B | 2.8% | 14 |
| Current FY 2026-06-30 |
$6.90 | $6.83 | $7.02 | 1.0% | -0.0% | 0↑ 19↓ | $87.1B | 3.4% | 23 |
| Next FY 2027-06-30 |
$7.09 | $6.96 | $7.34 | 2.7% | -0.1% | 0↑ 19↓ | $89.6B | 2.9% | 23 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.422 | |
| 7d ago | $1.423 | -0.000 |
| 30d ago | $1.425 | -0.002 |
| 60d ago | $1.523 | -0.101 |
| 90d ago | $1.529 | -0.107 |
10 analyst firms have rated this stock: 2 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 27, 2026 | UBS | MAINTAIN | Buy | Buy |
| Apr 27, 2026 | TD Cowen | MAINTAIN | Hold | Hold |
| Apr 27, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Apr 27, 2026 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Apr 17, 2026 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Apr 14, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Apr 10, 2026 | B of A Securities | MAINTAIN | Buy | Buy |
| Apr 8, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Apr 8, 2026 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| Apr 7, 2026 | UBS | MAINTAIN | Buy | Buy |
| Mar 30, 2026 | Deutsche Bank | MAINTAIN | Hold | Hold |
| Jan 27, 2026 | TD Cowen | DOWNGRADE | Buy | Hold |
| Jan 23, 2026 | UBS | MAINTAIN | Buy | Buy |
| Jan 23, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Jan 23, 2026 | JP Morgan | UPGRADE | Neutral | Overweight |
| Jan 14, 2026 | UBS | MAINTAIN | Buy | Buy |
| Jan 8, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Jan 5, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Dec 18, 2025 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Dec 17, 2025 | Jefferies | UPGRADE | Hold | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 8 | 14 | 13 | 1 | 0 | 61% | |
| May 1, 2026 | 8 | 14 | 12 | 1 | 0 | 63% | |
| Apr 1, 2026 | 8 | 14 | 12 | 1 | 0 | 63% | |
| Mar 1, 2026 | 8 | 14 | 12 | 1 | 0 | 63% | |
| Feb 1, 2026 | 8 | 14 | 12 | 1 | 0 | 63% | |
| Jan 1, 2026 | 8 | 15 | 12 | 0 | 0 | 66% | |
| Dec 1, 2025 | 7 | 15 | 13 | 0 | 0 | 63% | |
| Nov 1, 2025 | 7 | 15 | 13 | 0 | 0 | 63% |
Strong BuyBuyHoldSellStrong Sell
5 members of Congress traded this stock: 5 buys, 3 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | The Procter & Gamble Co | May 8, 2026 (12d) |
| Apr 27, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | The Procter & Gamble Co | May 8, 2026 (12d) |
| Feb 26, 2026 | John Boozman | R | SENATE | SELL | $1,001 - $15,000 | The Procter & Gamble Co | Mar 6, 2026 (9d) |
| Feb 26, 2026 | David Taylor | R | HOUSE | SELL | $1,001 - $15,000 | The Procter & Gamble Co | Mar 9, 2026 (12d) |
| Feb 17, 2026 | Lloyd Doggett | D | HOUSE | BUY | $1,001 - $15,000 | The Procter & Gamble Co | Mar 6, 2026 (18d) |
| Feb 9, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | The Procter & Gamble Co | Feb 23, 2026 (15d) |
| Feb 2, 2026 | Julia Letlow | R | HOUSE | BUY | $1,001 - $15,000 | The Procter & Gamble Co | Mar 13, 2026 (40d) |
| Jan 30, 2026 | Gilbert Cisneros | D | HOUSE | SELL | $1,001 - $15,000 | The Procter & Gamble Co | Feb 16, 2026 (18d) |
33°
Cool
Bearish
Neutral
Bullish
11 mentions
2 bullish
7 bearish
7 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 14, 2026 | 2 | 33° Cool | 0 | 2 | 2 |
| May 14, 2026 | 2 | 33° Cool | 0 | 2 | 2 |
| Apr 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 18, 2026 | 3 | 36° Cool | 0 | 2 | 3 |
| Mar 18, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Jan 29, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Jul 27, 2026
earnings_calendar
PG Q4 2026 Earnings After Market Close — 2026-07-27
EPS est: $1.58 | Rev est: $22.2B
Jun 4, 2026
Enforcement
The Scotts Co. LLC v. The Procter & Gamble Co.
Court ruling from Court of Appeals for the Sixth Circuit. Docket: 25-3555
Jun 1, 2026
Clinical Trial
Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea
Phase Phase 3 — TERMINATED
May 27, 2026
short_volume
Short Volume: PG — 58.9% short (2.1M / 3.6M)
Short: 2,105,903 | Exempt: 32,359 | TRF Vol: 3,572,379 | Short Ratio: 58.9% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: PG — 56.4% short (1.2M / 2.1M)
Short: 1,189,869 | Exempt: 3,335 | TRF Vol: 2,108,534 | Short Ratio: 56.4% | Off-exchange volume (dark pool + OTC)
May 18, 2026
dark_pool
Dark Pool: PG — 6.9M shares, 138,496 trades
Week starting 2026-05-18. Total ATS volume: 6,906,325 shares across 138,496 trades.
May 15, 2026
short_volume
Short Volume: PG — 62.0% short (1.6M / 2.6M)
Short: 1,637,989 | Exempt: 99,962 | TRF Vol: 2,640,360 | Short Ratio: 62.0% | Off-exchange volume (dark pool + OTC)
May 11, 2026
dark_pool
Dark Pool: PG — 7.7M shares, 151,396 trades
Week starting 2026-05-11. Total ATS volume: 7,683,161 shares across 151,396 trades.
May 8, 2026
short_volume
Short Volume: PG — 58.8% short (1.1M / 1.9M)
Short: 1,091,060 | Exempt: 4,260 | TRF Vol: 1,854,738 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
May 7, 2026
short_volume
Short Volume: PG — 59.9% short (1.3M / 2.2M)
Short: 1,318,804 | Exempt: 4,077 | TRF Vol: 2,201,752 | Short Ratio: 59.9% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_volume
Short Volume: PG — 59.8% short (1.8M / 3.0M)
Short: 1,807,127 | Exempt: 6,636 | TRF Vol: 3,019,886 | Short Ratio: 59.8% | Off-exchange volume (dark pool + OTC)
May 4, 2026
Clinical Trial
Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control.
Phase Phase 2 — COMPLETED
May 4, 2026
dark_pool
Dark Pool: PG — 7.7M shares, 147,275 trades
Week starting 2026-05-04. Total ATS volume: 7,747,725 shares across 147,275 trades.
Apr 28, 2026
short_volume
Short Volume: PG — 55.1% short (1.5M / 2.7M)
Short: 1,495,557 | Exempt: 24,102 | TRF Vol: 2,713,395 | Short Ratio: 55.1% | Off-exchange volume (dark pool + OTC)
Apr 27, 2026
short_volume
Short Volume: PG — 61.0% short (2.0M / 3.3M)
Short: 2,042,042 | Exempt: 4,112 | TRF Vol: 3,345,034 | Short Ratio: 61.0% | Off-exchange volume (dark pool + OTC)
Apr 27, 2026
dark_pool
Dark Pool: PG — 9.0M shares, 168,614 trades
Week starting 2026-04-27. Total ATS volume: 8,973,566 shares across 168,614 trades.
Apr 24, 2026
earnings_calendar
PG Q3 2026 Earnings Before Market Open — 2026-04-24
Apr 24, 2026
short_interest
FTD: PG — 5,793 shares ($0.8M) failed to deliver
Settlement: 20260424, Price: $145.71, FTD Value: $844,098.03, PROCTER & GAMBLE;COM NPV